356 related articles for article (PubMed ID: 9233569)
21. In vitro and in vivo properties of various types of platelets.
Rebulla P
Vox Sang; 1998; 74 Suppl 2():217-22. PubMed ID: 9704448
[TBL] [Abstract][Full Text] [Related]
22. Platelet membrane early activation markers during prolonged storage.
Matsubayashi H; Weidner J; Miraglia CC; McIntyre JA
Thromb Res; 1999 Feb; 93(4):151-60. PubMed ID: 10064270
[TBL] [Abstract][Full Text] [Related]
23. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival.
Rinder HM; Snyder EL; Tracey JB; Dincecco D; Wang C; Baril L; Rinder CS; Smith BR
Transfusion; 2003 Sep; 43(9):1230-7. PubMed ID: 12919425
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of platelet activation in leukocyte-depleted platelet concentrates during storage.
Vucic M; Stanojkovic Z; Antic A; Vucic J; Pavlovic V
Bosn J Basic Med Sci; 2018 Feb; 18(1):29-34. PubMed ID: 28926321
[TBL] [Abstract][Full Text] [Related]
25. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
Albanyan AM; Harrison P; Murphy MF
Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
[TBL] [Abstract][Full Text] [Related]
26. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
Ignatova AA; Karpova OV; Trakhtman PE; Rumiantsev SA; Panteleev MA
Vox Sang; 2016 Apr; 110(3):244-52. PubMed ID: 26646605
[TBL] [Abstract][Full Text] [Related]
27. Activation of platelet concentrate during preparation and storage.
Rinder HM; Snyder EL
Blood Cells; 1992; 18(3):445-56; discussion 457-60. PubMed ID: 1283703
[TBL] [Abstract][Full Text] [Related]
28. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
Sandgren P; Callaert M; Shanwell A; Gulliksson H
Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
[TBL] [Abstract][Full Text] [Related]
29. A comparison of platelet quality between platelets from healthy donors and hereditary hemochromatosis donors over seven-day storage.
Mikaelsdottir M; Vidarsson B; Runarsson G; Bjarnadottir U; Onundarson PT; Sigurjonsson OE; Halldorsdottir AM
Transfusion; 2021 Jan; 61(1):202-211. PubMed ID: 33166431
[TBL] [Abstract][Full Text] [Related]
30. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis.
Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki Y; Tomimatsu I; Ushida Y; Hosono F; Maeda K
Nephron; 2002 Apr; 90(4):391-400. PubMed ID: 11961397
[TBL] [Abstract][Full Text] [Related]
31. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
Singh S; Shams Hakimi C; Jeppsson A; Hesse C
Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
[TBL] [Abstract][Full Text] [Related]
32. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
33. In vitro effects of poly-N-acetyl glucosamine on the activation of platelets in platelet-rich plasma with and without red blood cells.
Valeri CR; Srey R; Tilahun D; Ragno G
J Trauma; 2004 Jul; 57(1 Suppl):S22-5; discussion S25. PubMed ID: 15280746
[TBL] [Abstract][Full Text] [Related]
34. Platelet activation during preparation and storage of concentrates: detection by flow cytometry.
Goodall AH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):377-82. PubMed ID: 1716482
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration.
Ferrer F; Rivera J; Corral J; González-Conejero R; Vicente V
Vox Sang; 2000; 78(4):235-41. PubMed ID: 10895097
[TBL] [Abstract][Full Text] [Related]
36. [Activation of random-donor platelet concentrates and platelet prepared from random-donor apheresis collections during storage].
Lin JJ; Fan HH; Ma Q; Feng ML; Shen XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):458-61. PubMed ID: 12513749
[TBL] [Abstract][Full Text] [Related]
37. The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates.
Feys HB; Van Aelst B; Devloo R; Vandekerckhove P; Compernolle V
Vox Sang; 2016 May; 110(4):344-51. PubMed ID: 26646710
[TBL] [Abstract][Full Text] [Related]
38. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia.
Ozsavci D; Yardimci T; Demirel GY; Demiralp E; Uras F; Onder E
Platelets; 2002 Jun; 13(4):223-9. PubMed ID: 12189024
[TBL] [Abstract][Full Text] [Related]
40. Annexin V and platelet antigen expression is not altered during storage of platelet concentrates obtained with the AMICUS cell separator.
Gutensohn K; Alisch A; Geidel K; Crespeigne N; Kuehnl P
Transfus Sci; 1999 Apr; 20(2):113-20. PubMed ID: 10539114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
